1. AB0550 DIFFUSING CAPACITY OF THE LUNG FOR CARBON MONOXIDE (DLCO) VS FORCED VITAL CAPACITY (FVC): SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS TO EXAMINE THEIR ABILITY TO MEASURE CHANGE IN CLINICAL TRIALS IN SYSTEMIC SCLEROSIS (SSC). (2nd June 2020) Authors: Bellando Randone, S.; Cappellini, E.; Nidiaci, L.; Lepri, G.; Lazzaroni, M. G.; Campochiaro, C.; Bagnato, G.; Sambataro, D.; Sambataro, G.; Matucci-Cerinic, M.; Furst, D. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0727 There is a Need for New Systemic Sclerosis Subset Criteria. A Content Analytic Approach. (9th June 2015) Authors: Johnson, S.R.; Fransen, J.; Khanna, D.; van den Hoogen, F.; Baron, M.; Matucci-Cerinic, M.; Denton, C.; Medsger, T.A.; Carreira, P.; Riemekasten, G.; Distler, J.; Gabrielli, A.; Steen, V.; Chung, L.; Silver, R.; Varga, J.; Muller-Ladner, U.; Vonk, M.; Walker, U.; Wollheim, F. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB1239 THE EFFECT OF INFLUENZA VACCINATION ON THE MULTI-BIOMARKER DISEASE ACTIVITY SCORE AND ITS COMPONENT BIOMARKERS IN HEALTHY SUBJECTS. (2nd June 2020) Authors: Furst, D.; Lenz, L.; Horton, M.; Flake, D.; Sasso, E.; Weinblatt, M. E. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1910 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB1283-HPR GASTROINTESTINAL INVOLVEMENT AND QUALITY OF LIFE IN A COHORT OF SYSTEMIC SCLEROSIS (SSC) PATIENTS. (13th June 2020) Authors: El Aoufy, K.; Antola, I.; Sciortino, C.; Bellando Randone, S.; Guiducci, S.; Furst, D.; Matucci-Cerinic, M. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1932 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0122 EFFICACY AND PATIENT-REPORTED OUTCOME MEASURES FROM A TWO-PART MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL TRIAL OF REPOSITORY CORTICOTROPIN INJECTION FOR PERSISTENTLY ACTIVE RHEUMATOID ARTHRITIS. (13th June 2020) Authors: Fleischmann, R.; Furst, D.; Wan, G.; Panaccio, M.; Liu, J.; Zhu, J.; Brasington, R. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0223 Long-term targeted safety event rates in ra patients following initiation of rituximab: interim analysis from sunstone registry. (23rd January 2014) Authors: Furst, D.; Winthrop, K. L.; Alexander, K. A.; Vashishtha, A.; Francom, S. F.; Saag, K. G. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0267 Mycophenolate Mofetil versus Oral Cyclophosphamide in Scleroderma-Related Interstitial Lung Disease: Scleroderma Lung Study II. (15th July 2016) Authors: Khanna, D.; Roth, M.; Clements, P.; Furst, D.; Tseng, C.-H.; Elashoff, R.; Volkmann, E.; Kafaja, S.; Goldin, J.; Tashkin, D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0275 Change in CXCL4 Levels May Predict Treatment Response in Systemic Sclerosis-Related Interstitial Lung Disease (SSC-ILD). (15th July 2016) Authors: Volkmann, E.; Tashkin, D.; Elashoff, R.; Tseng, C.-H.; Khanna, D.; Mayes, M.; Charles, J.; Clements, P.; Roth, M.; Furst, D.; Assassi, S. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0396 Double-blind comparison of mycophenolate mofetil and oral cyclophosphamide for treatment of scleroderma-related interstitial lung disease (scleroderma lung study [SLS] II): rationale, design, methods, baseline characteristics and patient disposition. (23rd January 2014) Authors: Khanna, D.; Roth, M.; Furst, D.; Clements, P.; Goldin, J.; Arriola, E.; Kotlerman, J.; Tseng, C.-H.; Kim, G.; Elashoff, R.; Tashkin, D. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. HLA class II susceptibility pattern for type 1 diabetes (T1D) in an Iranian population. (18th June 2015) Authors: Kiani, J.; Hajilooi, M.; Furst, D.; Rezaei, H.; Shahryari‐Hesami, S.; Kowsarifard, S.; Zamani, A.; Solgi, G. Journal: International journal of immunogenetics Issue: Volume 42:Number 4(2015:Aug.) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗